Article

July 19, 2012

ONC Says First Round of EHR Certification Bodies, Testing Labs Accredited

Read the full story: http://tinyurl.com/7n7c3cy

Source: ModernHealthcare.com

HHS' Office of the National Coordinator for Health Information Technology announced that five certification bodies and five testing labs are over their first hurdles toward participating in the federal electronic health-record system incentive payment program.

Related Videos

John Michael O'Brien, PharmD, MPH

4 experts are featured in this series.

5 experts are featured in this series

5 experts are featured in this series

Richard J. Nowak, MD, MS, Yale School of Medicine

4 experts are featured in this series.

Naim Alkhouri, MD

Christine Funke, MD

Related Content

Image credit: Pharmacy_Karanov images - stock.adobe.com

April 25th 2025

SGLT-2s, GLP-1s, Finerenone Have Unique Benefits in CKD, Diabetes: Meta-Analysis

Giuliana Grossi

The findings highlight important differences between therapies in managing blood glucose, blood pressure, lipids, and adverse effects in this high-risk patient population.

April 22nd 2025

New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix

Brooke McCormick Brady Post, PhD

On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.

Elderly woman holding her hands | Image credit: Evrymmnt - stock.adobe.com

April 25th 2025

Clinical, Real-World Data Support Importance of Tocilizumab for RA

AJMC Contributor

Tocilizumab has emerged as a key treatment for rheumatoid arthritis, showing efficacy, safety, and potential cardiovascular benefits in recent studies.

Managed Care Cast Thumbnail

April 15th 2025

Personalized Care Key as Tirzepatide Use Expands Rapidly

Maggie L. Shaw John W. Ostrominski, MD

Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.

NYOH’s Doyle on Joining OneOncology: What We Value the Most Is Culture

April 25th 2025

NYOH’s Doyle on Joining OneOncology: What We Value the Most Is Culture

New York Oncology and Hematology becomes the 27th practice in OneOncology.

glp-1 Wegovy, semaglutide | Image credit: Patrick Bay Damsted - stock.adobe.com

April 25th 2025

Can Medicare Sustain Widespread Access to GLP-1 Therapies?

Skylar Jeremias

Expanding Medicare coverage for glucagon-like peptide 1 (GLP-1) receptor agonists could significantly reduce obesity-related health issues, but it also risks adding tens of billions in new costs, highlighting the need for smart policy strategies to ensure access, affordability, and long-term sustainability.

Related Content

Image credit: Pharmacy_Karanov images - stock.adobe.com

April 25th 2025

SGLT-2s, GLP-1s, Finerenone Have Unique Benefits in CKD, Diabetes: Meta-Analysis

Giuliana Grossi

The findings highlight important differences between therapies in managing blood glucose, blood pressure, lipids, and adverse effects in this high-risk patient population.

April 22nd 2025

New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix

Brooke McCormick Brady Post, PhD

On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.

Elderly woman holding her hands | Image credit: Evrymmnt - stock.adobe.com

April 25th 2025

Clinical, Real-World Data Support Importance of Tocilizumab for RA

AJMC Contributor

Tocilizumab has emerged as a key treatment for rheumatoid arthritis, showing efficacy, safety, and potential cardiovascular benefits in recent studies.

Managed Care Cast Thumbnail

April 15th 2025

Personalized Care Key as Tirzepatide Use Expands Rapidly

Maggie L. Shaw John W. Ostrominski, MD

Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.

NYOH’s Doyle on Joining OneOncology: What We Value the Most Is Culture

April 25th 2025

NYOH’s Doyle on Joining OneOncology: What We Value the Most Is Culture

New York Oncology and Hematology becomes the 27th practice in OneOncology.

glp-1 Wegovy, semaglutide | Image credit: Patrick Bay Damsted - stock.adobe.com

April 25th 2025

Can Medicare Sustain Widespread Access to GLP-1 Therapies?

Skylar Jeremias

Expanding Medicare coverage for glucagon-like peptide 1 (GLP-1) receptor agonists could significantly reduce obesity-related health issues, but it also risks adding tens of billions in new costs, highlighting the need for smart policy strategies to ensure access, affordability, and long-term sustainability.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions